Russell Anderson

Cooley advised Redx Pharma, a UK clinical-stage biotechnology company, on its all share merger with Jounce Therapeutics, a US clinical-stage immunotherapy company, in a $425 million and contingent value right transaction.

Cooley advised Amryt Pharma, a Dublin, Ireland-based commercial-stage biopharmaceutical company, on its definitive agreement to be acquired by Chiesi Farmaceutici, a Parma, Italy-based research-focused biopharmaceuticals and healthcare group, in a $1.48 billion cash and contingent value right (CVR) transaction. Partners Bill Sorabella, Claire Keast-Butler and Bill Roegge led the joint US and UK Cooley team advising Amryt.

Cooley advised Chegg, a student-first connected learning platform, on its definitive agreement to acquire language learning platform Busuu for 385 million euros ($436 million). Partner Ben Shribman led the Cooley team advising Chegg.

Cooley advised Brandwatch, a global leader in digital consumer intelligence and social media listening, on its agreement to sell to public relations, marketing and social media management technology company Cision for $450 million. Partner Michal Berkner lead the Cooley team advising Brandwatch on the acquisition.

Cooley advised DocuSign, which helps organizations connect and automate how they prepare, sign, act on and manage agreements, on its agreement to acquire Seal Software, one of the leading contract analytics and artificial intelligence technology providers, for $188 million. Partner Michal Berkner led the Cooley team.